{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:24:52Z","timestamp":1758633892700},"reference-count":31,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/jcpt.12156","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T12:02:48Z","timestamp":1396612968000},"page":"376-382","source":"Crossref","is-referenced-by-count":4,"title":["The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital"],"prefix":"10.1155","volume":"39","author":[{"given":"I.","family":"Marqu\u00ednez-Alonso","sequence":"first","affiliation":[{"name":"Pharmacy Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Escudero-Vilaplana","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pern\u00eda","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bel\u00e9ndez Bieler","sequence":"additional","affiliation":[{"name":"Paediatric Oncohematology Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Fern\u00e1ndez-Llamazares","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sanjurjo-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Gregorio Mara\u00f1\u00f3n University General Hospital; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"10.1111\/jcpt.12156-BIB0001|jcpt12156-cit-0001","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0002|jcpt12156-cit-0002","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0003|jcpt12156-cit-0003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","article-title":"The pathogenesis of immune thrombocytopaenic purpura","volume":"133","author":"Cooper","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/jcpt.12156-BIB0004|jcpt12156-cit-0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2141.2009.07717.x","article-title":"Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production","volume":"146","author":"Nugent","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/jcpt.12156-BIB0005|jcpt12156-cit-0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0006|jcpt12156-cit-0006","unstructured":"Pacientes de P\u00farpura Tromb\u00f3citop\u00e9nica Idiop\u00e1tica (PTI) forman su Asociaci\u00f3n [Internet] Asociaci\u00f3n P\u00farpura Trombocitop\u00e9nica Espa\u00f1ola 2011 http:\/\/www.aptie.org\/Noticias-V239.html"},{"key":"10.1111\/jcpt.12156-BIB0007|jcpt12156-cit-0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0b013e3282ab98c7","article-title":"The epidemiology of immune thrombocytopenic purpura","volume":"14","author":"Fogarty","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/jcpt.12156-BIB0008|jcpt12156-cit-0008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","article-title":"Effect of intravenous immunoglobulin in immune thrombocytopenia","volume":"2","author":"Salama","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12156-BIB0009|jcpt12156-cit-0009","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12156-BIB0010|jcpt12156-cit-0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0140-6736(83)91738-5","article-title":"High-dose intravenous IgG in adults with autoimmune thrombocytopenia","volume":"1","author":"Newland","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12156-BIB0011|jcpt12156-cit-0011","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3476(85)80231-6","article-title":"Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin","volume":"106","author":"Bussel","year":"1985","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12156-BIB0012|jcpt12156-cit-0012","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","article-title":"Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone","volume":"349","author":"Cheng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12156-BIB0013|jcpt12156-cit-0013","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0014|jcpt12156-cit-0014","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2141.2003.04211.x","article-title":"Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis","volume":"120","author":"Bourgeois","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/jcpt.12156-BIB0015|jcpt12156-cit-0015","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0016|jcpt12156-cit-0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12156-BIB0017|jcpt12156-cit-0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-111-9-723","article-title":"Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women","volume":"111","author":"Ahn","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12156-BIB0018|jcpt12156-cit-0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2009-06-222448","article-title":"Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura","volume":"115","author":"Arnold","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0019|jcpt12156-cit-0019","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clpt.2004.08.010","article-title":"Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand","volume":"76","author":"Wang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12156-BIB0020|jcpt12156-cit-0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/jcpt.12156-BIB0021|jcpt12156-cit-0021","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12156-BIB0022|jcpt12156-cit-0022","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0023|jcpt12156-cit-0023","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1002625","article-title":"Romiplostim or standard of care in patients with immune thrombocytopenia","volume":"363","author":"Kuter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12156-BIB0024|jcpt12156-cit-0024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12156-BIB0025|jcpt12156-cit-0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12185-011-0886-8","article-title":"Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial","volume":"94","author":"Shirasugi","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1111\/jcpt.12156-BIB0026|jcpt12156-cit-0026","unstructured":"European Public Assessment Reports: Romiplostim Product Information http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000942\/WC500039537.pdf"},{"key":"10.1111\/jcpt.12156-BIB0027|jcpt12156-cit-0027","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1182\/blood-2011-03-340166","article-title":"Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program","volume":"118","author":"Khellaf","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0028|jcpt12156-cit-0028","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2010-10-313908","article-title":"A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia","volume":"118","author":"Bussel","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jcpt.12156-BIB0029|jcpt12156-cit-0029","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00277-011-1172-9","article-title":"Romiplostim in children with chronic refractory ITP: randomized placebo controlled study","volume":"90","author":"Elalfy","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1111\/jcpt.12156-BIB0030|jcpt12156-cit-0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/09537104.2011.619601","article-title":"Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia","volume":"23","author":"Mokhtar","year":"2012","journal-title":"Platelets"},{"key":"10.1111\/jcpt.12156-BIB0031|jcpt12156-cit-0031","first-page":"CD008235","article-title":"TPO receptor agonist for chronic idiopathic thrombocytopenic purpura","author":"Zeng","year":"2011","journal-title":"Cochrane Database Syst Rev Online"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12156","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12156\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:21Z","timestamp":1671818721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12156","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,4]]}}}